Related Experiment Video
Updated: May 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Respiratory tract infections in the immunocompromised
1UCLH Hospitals NHS Foundation, UK.
Pulmonary infections are a major concern for immunosuppressed patients, with rising antimicrobial resistance and complex, often mixed, infections. Early diagnosis and multidisciplinary care are crucial for improving outcomes in these vulnerable individuals.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pulmonology
Background:
- Pulmonary infections are a leading cause of morbidity and mortality in immunosuppressed patients.
- Emerging infectious threats and antimicrobial resistance complicate management.
- Fungal and viral pneumonias, alongside multidrug-resistant bacteria, pose significant challenges.
Purpose of the Study:
- To review current and emerging threats in pulmonary infections among immunosuppressed hosts.
- To discuss novel diagnostic approaches and therapeutic strategies.
- To highlight the growing issue of antimicrobial resistance.
Main Methods:
- Literature review of recent advancements in pulmonary infections in immunosuppressed hosts.
- Analysis of diagnostic modalities, including molecular methods.
- Evaluation of emerging treatment options and antimicrobial resistance patterns.
Main Results:
- Nosocomial pneumonia is increasingly caused by multidrug-resistant Gram-negative organisms.
- Viral pneumonias present atypically with high mortality; Aspergillosis and Mucorales infections are rising.
- Multidrug-resistant tuberculosis is increasing globally; mixed infections are common.
Conclusions:
- Pulmonary infections are frequent, complex, and often mixed in immunocompromised individuals.
- Early bronchoscopy with advanced diagnostics optimizes management and reduces mortality.
- Multidisciplinary care in specialist centers and new antimicrobial agents are essential.
Related Concept Videos
Microbiota of the Respiratory Tract
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

